These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 26994716)

  • 1. Influence of body composition profile on outcomes following colorectal cancer surgery.
    Malietzis G; Currie AC; Athanasiou T; Johns N; Anyamene N; Glynne-Jones R; Kennedy RH; Fearon KC; Jenkins JT
    Br J Surg; 2016 Apr; 103(5):572-80. PubMed ID: 26994716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Low Muscularity and Myosteatosis on Long-term Outcome After Curative Colorectal Cancer Surgery: A Propensity Score-Matched Analysis.
    Sueda T; Takahasi H; Nishimura J; Hata T; Matsuda C; Mizushima T; Doki Y; Mori M
    Dis Colon Rectum; 2018 Mar; 61(3):364-374. PubMed ID: 29377869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
    Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Muscularity and Myosteatosis Is Related to the Host Systemic Inflammatory Response in Patients Undergoing Surgery for Colorectal Cancer.
    Malietzis G; Johns N; Al-Hassi HO; Knight SC; Kennedy RH; Fearon KC; Aziz O; Jenkins JT
    Ann Surg; 2016 Feb; 263(2):320-5. PubMed ID: 25643288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer.
    Pedrazzani C; Conti C; Zamboni GA; Chincarini M; Turri G; Valdegamberi A; Guglielmi A
    Clin Nutr; 2020 Dec; 39(12):3763-3770. PubMed ID: 32336524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery.
    Pecorelli N; Carrara G; De Cobelli F; Cristel G; Damascelli A; Balzano G; Beretta L; Braga M
    Br J Surg; 2016 Mar; 103(4):434-42. PubMed ID: 26780231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Yin C; Narumi A; Omura Y; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Kobayashi M; Araki T; McMillan DC; Miki C; Kusunoki M
    JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1322-1333. PubMed ID: 29761898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chronic kidney disease on postoperative outcome following colorectal cancer surgery.
    Currie A; Malietzis G; Askari A; Nachiappan S; Swift P; Jenkins JT; Faiz OD; Kennedy RH
    Colorectal Dis; 2014 Nov; 16(11):879-85. PubMed ID: 24836209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Changes in Adipose Tissue Areas after Colectomy in Colorectal Cancer Patients.
    Choe EK; Park KJ; Ryoo SB; Moon SH; Oh HK; Han EC
    J Korean Med Sci; 2016 Oct; 31(10):1571-8. PubMed ID: 27550485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition and outcome in patients undergoing resection of colorectal liver metastases.
    van Vledder MG; Levolger S; Ayez N; Verhoef C; Tran TC; Ijzermans JN
    Br J Surg; 2012 Apr; 99(4):550-7. PubMed ID: 22246799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Visceral Obesity and Sarcopenia on Short-Term Outcomes After Colorectal Cancer Surgery.
    Chen WZ; Chen XD; Ma LL; Zhang FM; Lin J; Zhuang CL; Yu Z; Chen XL; Chen XX
    Dig Dis Sci; 2018 Jun; 63(6):1620-1630. PubMed ID: 29549473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical performance has a strong association with poor surgical outcome in older patients with colorectal cancer.
    Souwer ET; Moos SI; van Rooden CJ; Bijlsma AY; Bastiaannet E; Steup WH; Dekker JWT; Fiocco M; van den Bos F; Portielje JE
    Eur J Surg Oncol; 2020 Mar; 46(3):462-469. PubMed ID: 31899045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal Muscle Changes After Elective Colorectal Cancer Resection: A Longitudinal Study.
    Malietzis G; Currie AC; Johns N; Fearon KC; Darzi A; Kennedy RH; Athanasiou T; Jenkins JT
    Ann Surg Oncol; 2016 Aug; 23(8):2539-47. PubMed ID: 27006127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
    BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
    Nachit M; Horsmans Y; Summers RM; Leclercq IA; Pickhardt PJ
    Radiology; 2023 Jun; 307(5):e222008. PubMed ID: 37191484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer.
    Huang DD; Wang SL; Zhuang CL; Zheng BS; Lu JX; Chen FF; Zhou CJ; Shen X; Yu Z
    Colorectal Dis; 2015 Nov; 17(11):O256-64. PubMed ID: 26194849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.